I don't disagree that there are a lot of DNDN shareholders who are emotionally & perhaps financially overinvested in the stock, however, by comparing DNDN to the NFLD board, do you mean to suggest that DNDN will not so much as even get an approvable letter from the FDA?
you make reference to the outcome of the 9902B trial, implying that those results will be as disappointing as today's NFLD announcement (and thus lead to complete failure).
do you have any basis in fact for making such implications?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.